Stock market announcement archive

June 7, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF […]
Read more
June 6, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Member of the Board of Directors in Lifecare ASA and primary insider Tone Kvåle has today acquired 40 000 subscription rights […]
Read more
June 6, 2024
Bergen, Norway, June 6th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the company has concluded the sterilization protocol for production preparations, to be implemented in the automated sensor production. The Lifecare organization is working on preparations for automated production after a […]
Read more
June 4, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Teigland Eiendom AS has today exercised 2,623,948 subscription rights in the Rights Issue. Please see the attached PDMR-forms related to the […]
Read more
June 4, 2024
Bergen, Norway, June 4th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the company has filed an application for a new patent to the European Patent Office (EPO). Reference is made to previous communication of the potential of the sensor technology beyond […]
Read more
May 30, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Please see the attached PDMR-forms related to allocation of subscription rights to primary insiders and close associates of primary insiders in […]
Read more
May 30, 2024
Bergen, Norway, 30 May 2024: Today, at 13:00 CEST Lifecare CEO Joacim Holter will participate at Redeye Growth Day 2024 and present the latest development of the company. ****** Lifecare ASA is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare’s main focus is to bring the […]
Read more
May 30, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF […]
Read more
May 29, 2024
Reference is made to the previous stock exchange announcements published by Lifecare ASA (“Lifecare” or the “Company”) regarding the partially underwritten rights issue. Frequently asked questions (FAQ) on the Rights Issue is avalaible in the attachment. About usLifecare ASA is a clinical stage medical sensor company developing technology for sensing and monitoring of various body […]
Read more
May 29, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF […]
Read more